Reprogramming of adipose-derived stem cells of hepatic cancer patients into pluripotent stem cells
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

Supported by National Science Foundation for Distinguished Young Scholars(30925037).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    ObjectiveTo reprogram the adipose-derived stem cells of hepatic cancer patients into induced pluripotent stem cells (iPS cells). MethodsRetrovirus-based pMXs containing Oct4, Sox2, Klf4 and c-Myc were prepared and were used to infect adipose-derived stem cells; the infected cells were then cultured. Alkaline phosphatase staining, quantitative-PCR and immunofluorescence assay were used to identify the ES-cell-like colonies. ResultsThe ES-cell-like colonies expressed Alkaline phosphatase. Quantitative-PCR showed that ES-cell-like cells expressed the pluripotency genes of ES cells. Furthermore, immunofluorescence confirmed the expression of Oct4 and Sox2 in ES-cell-like cells. ConclusionAdipose-derived stem cells of hepatic cancer patients can be efficiently reprogrammed into iPS cells, and they can serve as the feeder layers of their own iPS cells. These findings may pave a way for improving efficiency of reprogramming adult cells and establishing hepatic cancer model for inducing pluripotent stem cells.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 13,2011
  • Revised:February 24,2011
  • Adopted:March 10,2011
  • Online: April 19,2011
  • Published:
Article QR Code